Mahony Susan's Insider Trades & SAST Disclosures
Mahony Susan's most recent trade in Axsome Therapeutics Inc was a trade of 1,312 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mahony Susan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Axsome Therapeutics Inc | Susan Mahony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 1,312 | 1,312 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Susan Mahony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 31,000 | 31,000 | - | - | Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Susan Mahony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 5,799 | 5,799 | - | - | Stock Option (Right to Buy) | |
| Assembly Biosciences Inc | Susan Mahony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 2,750 | 2,750 | - | - | Stock Option (right to buy) | |
| Axsome Therapeutics Inc | Mahony Susan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 191 | 191 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Susan Mahony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2023 | 37,000 | 37,000 | - | - | Stock Option (Right to Buy) | |
| Assembly Biosciences Inc | Susan Mahony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Horizon Therapeutics Plc | Susan Mahony | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 3,913 | 3,913 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Susan Mahony | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 3,913 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Susan Mahony | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.16 per share. | 28 Apr 2023 | 1,879 | 2,034 (0%) | 0% | 111.2 | 208,870 | Ordinary Shares |
| Zymeworks BC Inc | Susan Mahony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Assembly Biosciences Inc | Susan Mahony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Horizon Therapeutics Plc | Susan Mahony | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 4,223 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Susan Mahony | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 4,223 | 18,275 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Susan Mahony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 3,913 | 3,913 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Susan Mahony | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.56 per share. | 28 Apr 2022 | 1,658 | 16,617 (0%) | 0% | 98.6 | 163,412 | Ordinary Shares |
| Assembly Biosciences Inc | Susan Mahony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Horizon Therapeutics Plc | Susan Mahony | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 11,098 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Susan Mahony | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 11,098 | 18,409 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Susan Mahony | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.62 per share. | 29 Apr 2021 | 4,357 | 14,052 (0%) | 0% | 94.6 | 412,259 | Ordinary Shares |
| Horizon Therapeutics Plc | Susan Mahony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2021 | 4,223 | 4,223 | - | - | Restricted Stock Units | |
| Assembly Biosciences Inc | Susan Mahony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Zymeworks BC Inc | Susan Mahony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2020 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Susan Mahony | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2020 | 12,036 | 0 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Susan Mahony | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2020 | 12,036 | 12,036 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Susan Mahony | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 11,098 | 11,098 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Susan Mahony | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.62 per share. | 30 Apr 2020 | 4,725 | 7,311 (0%) | 0% | 35.6 | 168,305 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges